Rinvoq

AbbVie touts Rinvoq win in giant cell arteritis, potentially teeing up another label expansion
Fierce Pharma
Thu, 04/18/24 - 11:15 am
AbbVie
Rinvoq
clinical trials
giant cell arteritis
Rinvoq reclaims top Rx, OTC pharma brand crown
Medical Marketing and Media
Sun, 04/14/24 - 01:29 pm
AbbVie
Rinvoq
OTC advertising
As Humira plummets, AbbVie dials up Rinvoq and Skyrizi estimates to a combined $27B
Fierce Pharma
Fri, 02/2/24 - 11:58 am
AbbVie
earnings
Humira
Rinvoq
Skyrizi
AbbVie flexes litigation muscle with Rinvoq patent lawsuit against Sandoz, other generic players
Fierce Pharma
Wed, 11/22/23 - 11:39 am
AbbVie
Rinvoq
patents
legal
Sandoz
Sun Pharma
Intas Pharmaceuticals
AbbVie and Lupus Therapeutics partner for SLE trial recruitment
Clinical Trials Arena
Wed, 10/25/23 - 09:40 am
AbbVie
Lupus Therapeutics
systemic lupus erythematosus
lupus
Rinvoq
clinical trials
AbbVie’s Rinvoq shows long-term sustained efficacy in atopic dermatitis
Clinical Trials Arena
Thu, 10/12/23 - 10:02 am
AbbVie
clinical trials
Rinvoq
atopic dermatitis
Top Pharma Ad Spenders in August 2023, AbbVie Splurges to Take Top Spots
Xtalks
Sun, 10/1/23 - 01:28 pm
pharma advertising
DTC ads
AbbVie
Skyrizi
Rinvoq
Regeneron
AbbVie's Rinvoq passes midstage test in systemic lupus erythematosus, heads into phase 3
Fierce Pharma
Wed, 05/31/23 - 11:06 am
AbbVie
Rinvoq
Humira
systemic lupus erythematosus
lupus
clinical trials
AbbVie's Rinvoq scores its 7th FDA nod, this one for Crohn's disease
Fierce Pharma
Thu, 05/18/23 - 08:36 pm
AbbVie
FDA
Rinvoq
Crohn's Disease
Humira
AbbVie clinches back-to-back clinical wins in ulcerative colitis, lupus
BioSpace
Fri, 03/24/23 - 11:50 am
AbbVie
Skyrizi
ulcerative colitis
lupus
Rinvoq
clinical trials
AbbVie braces for 'greater erosion' of Humira franchise in second half of this year
Endpoints
Tue, 03/7/23 - 10:22 pm
AbbVie
Humira
Rinvoq
Top 10 Pharma TV Ad Spenders in 2022 — Anti-Inflammatories and Diabetes Drugs Dominate
Xtalks
Sun, 01/29/23 - 01:31 pm
television ads
pharma marketing
DTC ads
AbbVie
Rinvoq
Dupixent
Sanofi
Regeneron
Skyrizi
Novo Nordisk
Ozempic
Jardiance
Eli Lilly
Boehringer Ingelheim
Rybelsus
Trulicity
Rexulti
Otsuka
Lundbeck
Tremfya
JNJ
Verzenio
Looking past Humira, AbbVie boosts sales forecasts for successor drugs
BioPharma Dive
Wed, 01/11/23 - 12:22 pm
JPMHC 2023
AbbVie
Richard Gonzalez
Pharma CEOs
Humira
Skyrizi
Rinvoq
AbbVie Drops Autoimmune Candidate, Prioritizes Skyrizi and Rinvoq
BioSpace
Tue, 11/1/22 - 11:04 am
AbbVie
cedirogant
Skyrizi
Rinvoq
Humira
Where Will AbbVie Be in 3 Years?
Motley Fool
Fri, 09/30/22 - 10:50 am
AbbVie
Humira
biosimilars
Rinvoq
Skyrizi
Vraylar
This Blockbuster Drug from AbbVie Is Closer to Another Major Indication
Motley Fool
Tue, 07/5/22 - 11:05 am
Rinvoq
AbbVie
Europe
ulcerative colitis
AbbVie Redeems Priority Review Voucher for Rinvoq Approval
BioSpace
Thu, 06/23/22 - 07:53 pm
AbbVie
Rinvoq
priority review
priority review vouchers
ulcerative colitis
Third positive trial sets up filings for AbbVie’s Rinvoq in Crohn’s
Pharmaforum
Thu, 05/12/22 - 10:46 am
AbbVie
Rinvoq
clinical trials
Crohn’s disease
AbbVie's red-hot Rinvoq scores fourth FDA approval in five months
Fierce Pharma
Sat, 04/30/22 - 02:34 pm
AbbVie
Rinvoq
FDA
ankylosing spondylitis
Ahead of Humira's patent cliff, AbbVie's Rinvoq notches third new use in 4 months
Fierce Pharma
Thu, 03/17/22 - 11:33 pm
AbbVie
Rinvoq
ulcerative colitis
FDA

Pages